MLTX
NASDAQ · Biotechnology
Moonlake Immunotherapeutics
$11.53
+0.73 (+6.76%)
Open$11.14
Previous Close$10.80
Day High$11.55
Day Low$11.01
52W High$23.29
52W Low$9.46
Volume—
Avg Volume1.52M
Market Cap981.28M
P/E Ratio—
EPS$-3.83
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
-8.6% upside
Current
$11.53
$11.53
Target
$10.54
$10.54
$8.06
$10.54 avg
$16.98
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 207.37M | 195.61M | 178.47M |
| Net Income | -41,056,867 | -38,376,149 | -44,335,912 |
| Profit Margin | -19.8% | -19.6% | -24.8% |
| EBITDA | -81,449,014 | -69,654,675 | -60,804,840 |
| Free Cash Flow | -45,845,658 | -33,391,408 | -32,934,200 |
| Rev Growth | +19.2% | +9.7% | +1.7% |
| Debt/Equity | 0.11 | 0.10 | 0.12 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $293.30 | +0.68% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $465.23 | +1.04% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.32 | +1.46% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $550.87 | +0.69% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $919.96 | +1.73% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.61 | +0.43% | 7.7 | 20.98B |